DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Molbio Diagnostics Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·8 Oct 2026, 7:41 am

Molbio Diagnostics

Molbio Diagnostics Limited has filed a certificate with stock exchanges to comply with SEBI’s Depositories and Participants Regulations for the quarter ending September 30, 2026. This document confirms that the company has met all regulatory requirements related to its shareholding patterns and depository activities during the specified period.

This filing is a routine administrative step that ensures transparency and regulatory compliance. For investors, it signals that the company is adhering to established governance standards, which is generally a positive indicator of operational discipline. The move does not directly impact the company's financial performance or business strategy but reinforces its commitment to regulatory norms.

Investors should monitor the company's future filings for any material disclosures. While this specific update is procedural, consistent compliance is a key factor in maintaining investor confidence and trust in the company's management.